Matrimed

Fentanyl, the active ingredient in Matrimed, is an opioid analgesic presented as a transdermal patch for transdermal use. It provides continuous systemic delivery of fentanyl to manage chronic cancer pain and severe chronic non‑cancer pain in adult patients who require around‑the‑clock opioid therapy.

GNH USA supplies Matrimed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide, providing reliable sourcing and regulatory‑aligned distribution for this EU‑market product with comprehensive established quality‑assurance processes and export expertise.

Fentanyl is an opioid analgesic used for severe persistent pain conditions.

Chronic cancer pain: provides continuous opioid analgesia to reduce pain intensity and improve quality of life. Severe chronic non‑cancer pain: delivers steady fentanyl levels to control pain that is unresponsive to other therapies. Breakthrough pain management (adjunct): used in conjunction with immediate‑release opioids to address episodic pain spikes.

Fentanyl transdermal therapy may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate feeling of sickness. - Constipation: reduced bowel movements. - Dizziness: light‑headed sensation. - Application site reactions: erythema, itching, or rash at the patch site.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be life‑threatening. - Severe hypotension: marked drop in blood pressure. - Opioid dependence or withdrawal: signs of physical dependence with abrupt discontinuation.

When prescribing or handling Matrimed, several safety measures should be observed to minimize risks.

- Patient selection: assess opioid tolerance and contraindications before initiating therapy. - Dose titration: start with the lowest effective patch strength and adjust cautiously. - Concomitant CNS depressants: avoid or closely monitor use with benzodiazepines or alcohol. - Respiratory status: monitor patients with compromised breathing or sleep‑disordered breathing. - Pregnancy and lactation: use only if benefits outweigh potential risks, as safety data are limited. - Store at room temperature: keep patches below 25 °C in the original packaging, protected from moisture and direct sunlight.

Fentanyl may interact with other medicines, altering its analgesic effect or increasing adverse events.

Major Interactions (Avoid): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can raise fentanyl plasma levels, risking respiratory depression. - CNS depressants (e.g., benzodiazepines, barbiturates, alcohol): additive sedation and respiratory suppression. - MAO inhibitors: may precipitate severe hypotension or serotonin syndrome.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce fentanyl efficacy. - Serotonergic agents (e.g., SSRIs, SNRIs, tramadol): increase risk of serotonin syndrome. - Diuretics: may enhance orthostatic hypotension.